查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1560212

mRNA 疫苗市场报告：2030 年趋势、预测与竞争分析

mRNA Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

mRNA 疫苗的趋势和预测

到2030年，全球mRNA疫苗市场预计将达到268亿美元，2024年至2030年的复合年增长率为8.3%。该市场的主要驱动力是对新疫苗和治疗方法的需求激增以及患有慢性病和感染疾病的患者数量不断增加。全球 mRNA 疫苗市场前景广阔，医院/诊所市场和研究设施市场充满机会。

Lucintel 预测，癌症免疫疗法将在预测期内达到最高成长。

在这个市场中，由于疫苗接种方便、训练有素的医务人员以及先进的医疗基础设施，越来越多的患者更喜欢医院和诊所，医院和诊所仍将是最大的细分市场。

由于人口中感染疾病的流行、强大的医疗基础设施以及主要企业的存在，预计北美仍将是最大的地区。

mRNA疫苗市场新趋势

mRNA 疫苗市场充满活力，预计有许多趋势将塑造其未来。其背景是技术的传播、研究活动的活性化以及市场对先进疫苗技术的高需求。

  • 更广泛的使用案例：除了 COVID-19 大流行之外，mRNA 技术还扩大了在开发疫苗和治疗方法更多疾病（包括癌症和遗传异常）方面的应用。这一趋势是应对传染病研究工作的延伸。
  • 标靶疫苗：根据每位患者的遗传特征製备个人化的mRNA疫苗是一种日益增长的趋势，特别是在癌症治疗中。这一趋势旨在开发针对患者特定疾病标记的有效疫苗。
  • 增强的生产工艺：生产过程的发展改进了 mRNA 疫苗的生产工艺，使大规模生产变得更容易、更便宜。这一趋势不仅对于最大限度地降低生产成本很重要，而且对于增加疫苗的使用也很重要。
  • 国际伙伴关係：国际合作正在加强 mRNA 技术的研究和开发工作。公司、国家和研究中心的联合行动将促进创造新 mRNA 疫苗的创造力和速度。
  • 监管演变：随着mRNA疫苗的使用越来越频繁，监管机构也与时俱进，改革可能带来潜在风险的结构性问题。这项进展还包括 mRNA 疫苗核准流程和安全要求的更新，旨在促进其正确融入医疗保健系统。

这些趋势正在重塑 mRNA 疫苗市场，并透过扩大应用范围、改进製造方法和吸引国际合作来扩大其开拓。这些趋势正在鼓励新的想法并改变 mRNA 疫苗的使用，以更有效的方式涵盖更广泛的疾病。

mRNA疫苗市场的最新趋势

mRNA 疫苗市场的新兴模式表明该领域取得了重大进展并扩大了其效用。像这样开拓新兴国家市场，无论从市场前景或是疫苗研发生产流程来说，都是大势所趋。

  • 新疫苗的核准：最近，mRNA疫苗在治疗病毒和恶性疾病方面的潜力已被认识并正在获得核准。目前的这些进展似乎为 mRNA 技术的更广泛应用奠定了基础。
  • 技术创新：mRNA 技术正在取得进步，包括提高递送系统稳定性以提高疫苗功效。一旦开发出来，mRNA 疫苗可能会变得更有效、更容易使用。
  • 增加投资：公共和私人投资者对加速 mRNA 疫苗开发的兴趣日益浓厚。在这种情况下，将为反应过程和其他必要疫苗的生产以及提高生产能力提供财政援助。
  • 全球生产扩张：将透过建立更多设施来安排暂停 mRNA 疫苗生产设施的产能限制。建立此类设施是为了满足不断增长的全球疫苗市场并确保可靠的疫苗供应。
  • 研究合作：生物技术公司、大学和政府之间正在建立更紧密的联繫，以加速基于 mRNA 技术的疫苗开发。这些特定营业单位的合作正在促进基于 mRNA 的疫苗开发的进展。

这些进步透过更广泛的应用、改进的技术以及市场内更高水准的投资和商业活动，巩固了 mRNA 疫苗市场领域的扩张。由于它是一个活跃且快速变化的行业领域，未来性充满希望。

mRNA 疫苗市场的策略性成长机会

mRNA疫苗市场为各种类型的应用提供了成长的策略选择。不断评估新兴市场的此类机会将有助于相关人员适应新趋势并提高其市场占有率。

  • 癌症免疫疗法：这是一个快速发展的领域，正在开发 mRNA 疫苗来治疗癌症。目前正在进行临床试验的个人化 mRNA 癌症疫苗的开发备受期待，并有可能改变传统的癌症治疗。
  • 感染疾病疫苗：mRNA 疫苗的其他市场包括流感和 RSV，提供了成长机会。该技术的多功能性使得能够对新出现的感染疾病做出快速反应。
  • 联合疫苗：有机会将针对不同疾病的mRNA疫苗联合起来，具有巨大的策略性利益。透过此类策略可以提高疫苗的功效和易用性，从而增加其对更广泛市场的吸引力。
  • 全球市场的扩大：mRNA疫苗的使用提供了更大的成长潜力，特别是在尚未开始使用现有疫苗技术的地区，例如开发中国家。我们需要优先考虑 mRNA 疫苗的民主化和降低价格。
  • 研发合作：在市场开拓，由于与其他国家联合研发的好处得到更好的了解，新型mRNA疫苗的开发预计将快速成长。这种合作创造了一个共用资源和知识的平台，从而促进市场成长。

这些成长机会凸显了针对各种健康状况的 mRNA 疫苗的潜在应用和市场扩张。所有相关人员都可以利用这些机会，根据新趋势加强疫苗市场的开拓。

mRNA疫苗市场的驱动因素与挑战

mRNA疫苗市场存在各种驱动因素​​和挑战，以及影响市场发展和成长的挑战。了解这些因素对于正确驾驭市场非常重要。

推动 mRNA 疫苗市场的因素包括：

1.技术进步：随着疫苗变得更加有效和安全，mRNA技术的新发展将继续推动市场成长。输送系统和稳定技术的改进正在提高疫苗的品质。

2. 支出增加：政府机构和非政府组织资金的增加刺激了mRNA疫苗的研究和开发。这笔资金将有助于开发其他候选疫苗并扩大生产规模。

3.不断成长的疫苗市场：mRNA技术是开发各种治疗性疫苗的通用方法。

4.有利的法规环境：法规环境的有利措施促进了mRNA疫苗的核准和使用。关于安全问题，我们也在考虑需要采取什么措施以及需要多长时间。

5. 改善跨国交流：全球交流与合作使mRNA疫苗研发变得更容易。专家和材料的结合创造了新的想法并扩大了市场。

mRNA 疫苗市场面临的挑战包括：

1.生产成本高：mRNA疫苗的生产价格仍然较高，阻碍了疫苗的经济可用性。提高生产效率是阻碍进一步市场渗透的因素之一。

2.一定的监管：随着mRNA疫苗的新普及，mRNA疫苗开发者的相关性相当高，新兴市场通常令人期待。

3.现有技术的可利用性：由于高成本和技术超越的矛盾，实现高成长可能存在障碍。然而，透过有效利用这些障碍，你可以有效地扩展你的范围。

mRNA疫苗市场存在的驱动因素和挑战与技术进步状况、投资模式和管理体制本身有很大关係，因为它们影响市场向某个方向的开拓。为了在这个行业中取得成功，必须解决这些问题并实现预期的市场目标。

mRNA 疫苗按市场

本研究按类型、应用、最终用途和地区对全球 mRNA 疫苗进行了预测。

mRNA疫苗市场的国家展望

全球主要市场的mRNA疫苗市场正在发生重大变化和发展。市场的成长机会和转型是由技术发展、监管核准和扩大使用范围等因素所驱动的。美国、中国、德国、印度和日本是引领这一趋势的国家之一，它们都在以某种方式改进其 mRNA 疫苗技术。

  • 美国：美国mRNA 疫苗的新进展现在正在被设计者看到，包括用于其他疾病的应用，包括癌症和流感。该公司正在开发新的以 mRNA 为重点的补充疫苗和其他治疗扩展资产。美国也正在考虑为疫苗无效的疾病的治疗提供资金。
  • 中国 中国有几家本土生技公司目前正在开发 mRNA COVID-19 疫苗和其他类型的感染疾病疫苗，其中包括 BioNTech 在中国的被授权者。中国政府正在透过资金和合作伙伴关係促进这一成长，目标是成为 mRNA 领域的全球领导者。
  • 德国 总部位于德国的 BioNTech 旨在进一步提高其在 mRNA 疫苗方面的研发能力，包括治疗各种癌症和其他罕见疾病。我们也正在扩大我们的生产设施并参与有关 mRNA 研究方法和分销的国际伙伴关係关係。
  • 印度 印度的目标是开发一种廉价的 mRNA 疫苗，以帮助控制当地的健康挑战，特别是寒冷季节的 COVID-19 病毒株和流感。印度生物技术公司正在寻求国际合作伙伴，以增加 mRNA 疫苗的研究和製造。
  • 日本 日本的 mRNA 疫苗市场在疫苗配方和製造技术的新发展方面取得了进展。此外，日本公司正在研究mRNA癌症疫苗和罕见疾病疫苗，并试图将其纳入日本的医疗体系。

常问问题

Q.1 mRNA疫苗的市场规模有多大？

A1. 到 2030 年，全球 mRNA 疫苗市场预计将达到 268 亿美元。

Q.2 mRNA疫苗市场的成长预测如何？

A2. 2024年至2030年，全球mRNA疫苗市场预计将以8.3%的复合年增长率成长。

Q.3 影响 mRNA 疫苗市场成长的关键驱动因素有哪些？

A3.该市场的主要驱动力是对新疫苗和疗法的需求激增以及慢性病和感染疾病患者数量的增加。

Q4.市场的主要细分市场是：

A4. mRNA疫苗市场的未来在医院/诊所市场和研究机构市场看来前景看好。

Q5.市场的主要企业是：

A5. 主要mRNA疫苗公司如下：

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计癌症免疫疗法将在预测期内达到最高成长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于人口中感染疾病的流行、强大的医疗基础设施以及主要企业的存在，北美将继续成为最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球mRNA疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球mRNA疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 全球 mRNA 疫苗市场（按类型）
    • 自扩增 mRNA 疫苗 (SAM)
    • 传统非扩增 mRNA 疫苗
  • 全球 mRNA 疫苗市场（依应用）
    • 癌症免疫治疗
    • 过敏耐受性
    • 治疗性疫苗
  • 全球 mRNA 疫苗市场（依最终用途）
    • 医院/诊所
    • 实验室
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球 mRNA 疫苗市场（按地区）
  • 北美mRNA疫苗市场
  • 欧洲mRNA疫苗市场
  • 亚太地区mRNA疫苗市场
  • 其他地区mRNA疫苗市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球 mRNA 疫苗市场的成长机会（按类型）
    • 全球 mRNA 疫苗市场成长机会（按应用）
    • 全球 mRNA 疫苗市场成长机会（依最终用途）
    • 全球 mRNA 疫苗市场成长机会（按地区）
  • 全球 mRNA 疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球mRNA疫苗市场产能扩张
    • 全球 mRNA 疫苗市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo
简介目录

mRNA Vaccine Trends and Forecast

The future of the global mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets. The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Within this market, hospital & clinic will remain the largest segment due to growing patients preference for this facilities because of the convenient access to vaccinations, availability of trained medical personnel, and existence of advanced healthcare infrastructure.

North America will remain the largest region due to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Emerging Trends in the mRNA Vaccine Market

The mRNA vaccine market is dynamic and changing with many trends that are expected to influence the future of it. This is driven by the proliferation of technology, increased research activities and high market demand for advanced vaccine technologies.

  • Broader Use Cases: mRNA technology is extending its application in the development of vaccines and therapies for more diseases in addition to the COVID-19 pandemic, for instance, cancer and genetic anomalies. This trend is an extension of the research bean in addressing contagious diseases.
  • Target-Oriented Vaccines: There is an increasing trend toward the preparing individualized mRNA vaccines depending on the genetics of individual patients especially in the treatment of cancers. This trend seeks to achieve effective vaccines designed for specific disease markers in patients.
  • Enhanced Production Processes: The growth of the production processes is improving the mRNA vaccine production processes by making it easier and cheaper to produce on a larger scale. This trend is important in the enhancement of vaccine usage as well as the minimization of production costs.
  • International Partnerships: International outreach is enhancing mRNA technology research and development endeavors. Joint actions of companies, countries and research centers sponsor creativity and the speed of new mRNA vaccines creation.
  • Regulatory Evolution: As mRNA vaccines are used more often, regulators are moving with the time and reforming structural issues which may pose potential risk. This trend includes updating the approval procedures and even the requirements for safety of mRNA vaccines aimed at promoting their proper integration in health care systems.

These trends are reshaping the mRNA vaccine market and expanding its development by broadening the scope of application, enhancing the methods of production and attracting international collaboration. They are encouraging new ideas and transforming the utilization of mRNA vaccines to cover a broader spectrum of diseases in a more efficient manner.

Recent Developments in the mRNA Vaccine Market

Emerging patterns in the mRNA vaccine market signal remarkable progress in this field and its expanding utility. Such developments are the order of the day as far as the outlook of the market is concerned and even the flow of vaccine development and manufacture.

  • New Vaccine Approvals: Lately the potential of mRNA vaccines in treating viral and even malignant diseases is being recognized and approved which is broadening the market. These current activities seem to be providing a foundation toward wider utilization of the mRNA technology.
  • Technological Innovations: MRNA technology advancement's such as vaccine undergoing refinement delivery systems stability enhancing vaccines efficacy are being realized. These as they are developed shall make mRNA vaccines more effective and easy to use.
  • Increased Investment: There has been an upsurge in appetite from public and private investors to facilitate the furtherance of mRNA vaccines. In such cases funding such as these will assist in the reaction processes or in the making of other necessary vaccines and boosting manufacturing capacities.
  • Global Manufacturing Expansion: This halt in the production capacity restriction for manufacturing facilities of mRNA vaccines is sorted by the establishment of further such facilities. Such facilities are being set up to satisfy the increasing the global market for vaccines and also for ensuring reliable vaccine supplies.
  • Research Collaborations: Stronger links are forged between biotech companies and universities with the government allowing the faster development of vaccines based on the mRNA technology. The collaboration of these specific types of entities is fostering progress in mRNA-based vaccine development.

Such advances are consolidating the expansion of the mRNA vaccine market sector through broader scope applications, bettering of technology, and enhancing the levels of investment and business activities within the market. They represent an industry segment that is active and rapidly changing and therefore has great future prospects.

Strategic Growth Opportunities for mRNA Vaccine Market

The market for mRNA vaccines gives different types of applications good strategic options for growth. Always assessing markets for such opportunities can also help the stakeholders to take to new trends and develop their presence in the market.

  • Cancer Immunotherapy: This is a fast-growing area whereby mRNA vaccines are developed for treating cancer. There is great hope in the development of personalized mRNA cancer vaccines in clinical trials that may change the treatment of cancer as we know it.
  • Vaccines for Infectious Diseases: Other markets for mRNA vaccines include influenza and RSV which offer opportunities for growth. Thanks to the technology's versatility, it enables quick response to newly emerging infectious diseases.
  • Combination Vaccines: There is an opportunity to have combined mRNA vaccines which target various diseases which is an excellent strategic benefit. Vaccine effectiveness and user-friendliness can be improved by such a strategy increasing its appeal to wider markets.
  • Global Market Expansion: The use of mRNA vaccines especially in regions like the developing nations that have not begun the use of the current vaccine technologies offers a bigger potential for growth. Efforts aimed at democratizing and cheapening the mRNA vaccines need to be pursued as a priority.
  • Research and Development Collaboration: The market witnesses rapid growth from the development of new mRNA vaccines through a greater understanding of the benefits of joint R&D with other countries. These collaborations create a platform for sharing resources and knowledge which promotes growth in the market.

These growth opportunities underscore the possibility of the application of mRNA vaccines to target different health conditions and their extended market reach. These opportunities may be used by any stakeholder to enhance the development of the vaccine market with new trends.

mRNA Vaccine Market Driver and Challenges

The mRNA vaccine market facilitates various drivers, in addition to challenges, which affect how the market can develop and grow. It is important to grasp such factors to be able to maneuver within the market appropriately.

The factors responsible for driving the MRNA vaccine market include:

1. Technological Progress: New developments in mRNA technology continue to propel the growth of the market as the vaccine becomes more effective and safe. Improvements in delivery systems and stabilization techniques are enhancing the quality of the vaccines.

2. Increased spending: The mRNA vaccine research and development is being stimulated through the provision of many resources from governmental and non-governmental organizations. Money helps the creation of other candidates for vaccines and the increase of the production scale.

3. Growing Vaccines Market: There is growing market growth because there is a growing demand for vaccines for various illnesses including but not limited to COVID-19 and cancer. mRNA technology is a universal approach for the development of different therapeutic vaccines.

4. Favorable Regulatory Environment: The approval and use of mRNA vaccines are being made easier by favorable actions in the regulatory environment. They are also addressing the issue of safety which measures need to be in place and how long the processes should take.

5. Improved Cross-border Interactions: Global interactions and collaborations have brought the implementation of mRNA vaccines closer. Combining the experts and materials encourages new ideas and broadens the market scope.

Challenges in the mRNA vaccine market are:

1. High Cost of Manufacturing: The price for manufacturing mRNA vaccines is still relatively high and this hinders the economical accessibility of the vaccines. Increasing production efficacy remains one of the hurdles to further penetration into the market.

2. Certain Set of Regulations: Emerging fashions of mRNA vaccines ensure the relevance of mRNA vaccine developers to be rather high and emerging new markets are usually expected.

3. Existing or Absence of Technology: There could be barriers to the implementation of high growth due to high costs, and inconsistencies owing to the changes - technological transcendence. However, one is utterly aware of the benefits rendered by the use of these hindrances for the effective development of scope.

As the drivers and challenges present in the mRNA vaccine market affect the developments of the market towards a certain direction, these relate rather to the state of advancement in the technology, the patterns of investment, and the very regulatory regime. To succeed in the industry, it is imperative to deal with these issues to achieve the desired market goals.

List of mRNA Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mRNA vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mRNA vaccine companies profiled in this report include-

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo

mRNA Vaccine by Segment

The study includes a forecast for the global mRNA vaccine by type, application, end use, and region.

mRNA Vaccine Market by Type [Analysis by Value from 2018 to 2030]:

  • Self-Amplifying mRNA Vaccines (SAM)
  • Conventional Non-Amplifying mRNA Vaccines

mRNA Vaccine Market by Application [Analysis by Value from 2018 to 2030]:

  • Cancer Immunotherapy
  • Allergy Tolerization
  • Therapeutic Vaccines

mRNA Vaccine Market by End Use [Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Research Laboratories
  • Others

mRNA Vaccine Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the mRNA Vaccine Market

Significant changes and progress in the mRNA vaccine market have been experienced in the key markets around the world. Growth opportunities and transformations in the market are being driven by factors such as technological developments, approvals by regulatory authorities and increasing scopes of use. The United States, China, Germany, India and Japan are some of the countries leading these trends, with all of them improving the mRNA vaccine technology in one aspect or another.

  • United States: In the US, at the present time new developments of mRNA vaccines include the designers' inclusion of its application for additional diseases such as cancer and other illnesses including influenza. The company is developing its new mRNA-focused replenishment vaccines and other treatment expansion assets. The United States is also considering funding against disease treatment where vaccine measures would not be effective
  • China: There are several local bio-tech companies in China, including BioNTech's Chinese licensee, which are now developing mRNA COVID-19 vaccines and other types of Infectious disease vaccines. The Chinese government has been promoting this growth with funds and collaborations, with the objective of dominating the mRNA sector globally.
  • Germany: With BioNTech headquartered in Germany, the country has made it a goal to further its mRNA vaccine R&D capabilities so as to include treatment for different cancers and other rare diseases. The country is also boosting its manufacturing facilities and participating in international partnerships regarding mRNA research methods and distribution practices.
  • India: In India, the objectives are to create cheap mRNA vaccines which would help control the local health challenges, especially COVID-19 strains and flu during cold seasons. Indian biotech companies are looking for international partners to strengthen the efforts towards the research and manufacturing of mRNA vaccines.
  • Japan: The Japanese market for mRNA vaccines has recorded progress with regard to new developments in vaccine formulations and production technologies. In addition, Japanese companies are looking into mRNA cancer vaccines and rare disease vaccines and incorporating them into the health care system in Japan.

Features of the Global mRNA Vaccine Market

Market Size Estimates: mRNA vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: mRNA vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: mRNA vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the mRNA vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mRNA vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the mRNA vaccine market size?

Answer: The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030.

Q.2 What is the growth forecast for mRNA vaccine market?

Answer: The global mRNA vaccine market is expected to grow with a CAGR of 8.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mRNA vaccine market?

Answer: The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

Q4. What are the major segments for mRNA vaccine market?

Answer: The future of the mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets.

Q5. Who are the key mRNA vaccine market companies?

Answer: Some of the key mRNA vaccine companies are as follows:

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo

Q6. Which mRNA vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Q7. In mRNA vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the mRNA vaccine market by type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA vaccines), application (cancer immunotherapy, allergy tolerization, and therapeutic vaccines), end use (hospitals & clinics, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
  • Market Report

Table of Contents

1. Executive Summary

2. Global mRNA Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global mRNA Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global mRNA Vaccine Market by Type
    • 3.3.1: Self-Amplifying mRNA Vaccines (SAM)
    • 3.3.2: Conventional Non-Amplifying mRNA Vaccines
  • 3.4: Global mRNA Vaccine Market by Application
    • 3.4.1: Cancer Immunotherapy
    • 3.4.2: Allergy Tolerization
    • 3.4.3: Therapeutic Vaccines
  • 3.5: Global mRNA Vaccine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Research Laboratories
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global mRNA Vaccine Market by Region
  • 4.2: North American mRNA Vaccine Market
    • 4.2.1: North American mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.2.2: North American mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.3: European mRNA Vaccine Market
    • 4.3.1: European mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.3.2: European mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.4: APAC mRNA Vaccine Market
    • 4.4.1: APAC mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.4.2: APAC mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.5: ROW mRNA Vaccine Market
    • 4.5.1: ROW mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.5.2: ROW mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global mRNA Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global mRNA Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global mRNA Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global mRNA Vaccine Market by Region
  • 6.2: Emerging Trends in the Global mRNA Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global mRNA Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global mRNA Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Moderna
  • 7.3: BioNTech
  • 7.4: GlaxoSmithKline
  • 7.5: Daiichi Sankyo